Schedule 13G ownership disclosure

APYX MEDICAL CORPORATION

Common Stock, $0.001 par value per share · CUSIP: 03837C106

Event date: 2026-10-21

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • Philotimo Fund, LP

    Shares: 1,425,473.00 · Class: 3.4%

  • Philotimo Focused Growth & Income Fund

    Shares: 855,045.00 · Class: 2.0%

  • Kanen Wealth Management LLC

    Shares: 2,280,518.00 · Class: 5.4%

  • Kanen David

    Shares: 2,280,518.00 · Class: 5.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001688522-26-000006
Form type
SCHEDULE 13G
Filer
Philotimo Fund, LP
CIK
CIK 1688522
Filed
Oct 28, 2026
Reporting period
Oct 21, 2026
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub